Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment.
Ozalp
O
Ekinci
Osman
O
Sabuncuoglu
D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000068180:Aripiprazole; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000009:adverse effects* / Q000627:therapeutic use; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011605:Psychoses, Substance-Induced / Q000209:etiology*; D015363:Quinolones / Q000009:adverse effects* / Q000627:therapeutic use; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use
D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants; D010879:Piperazines; D015363:Quinolones; D008774:Methylphenidate; D000068180:Aripiprazole; D018967:Risperidone